Frailty in HIV-Infected Adults in South Africa
Open Access
- 1 January 2013
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 62 (1), 43-51
- https://doi.org/10.1097/qai.0b013e318273b631
Abstract
Objectives: Some evidence suggests that HIV infection is associated with premature frailty—a syndrome typically viewed as being related to ageing. We determined the prevalence and predictors of frailty in a population of HIV-infected individuals in South Africa. Design: Case-control study of 504 adults more than the age of 30 years, composed of 248 HIV-infected adults and 256 age- and gender-matched, frequency-matched HIV-seronegative individuals. Methods: Frailty was defined by standardized assessment comprised of ≥3 of weight loss, low physical activity, exhaustion, weak grip strength, and slow walking time. Independent predictors of frailty were evaluated using multivariable logistic regression. Results: The mean ages of the HIV-infected and HIV-seronegative groups were 41.1 ± 7.9 years and 42.6 ± 9.6 years, respectively. Of the HIV-infected adults, 87.1% were receiving antiretroviral treatment (median duration, 58 months), their median CD4 count was 468 cells/μL (interquartile range = 325–607 cells/μL) and 84.3% had undetectable plasma viral load. HIV-infected adults were more likely to be frail than HIV-seronegative individuals (19.4% vs. 13.3%; P = 0.07), and this association persisted after adjustment for confounding variables [adjusted OR = 2.14; 95% confidence interval (95% CI): 1.16–3.92, P = 0.01]. Among HIV-infected individuals, older age was a strong predictor of frailty, especially among women (women: OR = 2.55 per 10-year age increase; men: OR = 1.29 per 10-year age increase, P-interaction = 0.01). Lower current CD4 count (P = 0.04). Conclusions: HIV infection is associated with premature development of frailty, especially in women. Since higher CD4 counts were associated with lower risk of frailty, earlier initiation of antiretroviral treatment may be protective.Keywords
This publication has 34 references indexed in Scilit:
- Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) studyClinical Trials, 2012
- A Frailty-Related Phenotype Before HAART Initiation as an Independent Risk Factor for AIDS or Death After HAART Among HIV-Infected MenThe Journals of Gerontology: Series A, 2011
- HIV infection in older adults in sub-Saharan Africa: extrapolating prevalence from existing dataPublished by WHO Press ,2010
- Causes of Death in HIV‐1–Infected Patients Treated with Antiretroviral Therapy, 1996–2006: Collaborative Analysis of 13 HIV Cohort StudiesClinical Infectious Diseases, 2010
- Frailty among HIV-infected persons in an urban outpatient care settingJournal of Infection, 2009
- Relationship Between a Frailty-Related Phenotype and Progressive Deterioration of the Immune System in HIV-Infected MenJAIDS Journal of Acquired Immune Deficiency Syndromes, 2009
- Frailty Among Community-Dwelling Elderly People in France: The Three-City StudyThe Journals of Gerontology: Series A, 2008
- Do Patterns of Comorbidity Vary by HIV Status, Age, and HIV Severity?Clinical Infectious Diseases, 2007
- HIV-1 Infection Is Associated With an Earlier Occurrence of a Phenotype Related to FrailtyThe Journals of Gerontology: Series A, 2007
- Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis controlAIDS, 2006